Documents
Application Sponsors
NDA 210895 | DAIICHI SANKYO INC | |
Marketing Status
Application Products
001 | BAR, CHEWABLE;ORAL | 3.75GM | 1 | WELCHOL | COLESEVELAM HYDROCHLORIDE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2019-04-03 | STANDARD |
Submissions Property Types
CDER Filings
DAIICHI SANKYO INC
cder:Array
(
[0] => Array
(
[ApplNo] => 210895
[companyName] => DAIICHI SANKYO INC
[docInserts] => ["",""]
[products] => [{"drugName":"WELCHOL","activeIngredients":"COLESEVELAM HYDROCHLORIDE","strength":"3.75GM","dosageForm":"BAR, CHEWABLE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
[labels] => [{"actionDate":"05\/12\/2020","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/022362s027,021776s047,210895s001lbl.pdf\"}]","notes":""},{"actionDate":"04\/03\/2019","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/210895s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"04\/03\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 3 - New Dosage Form","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/210895s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/210895Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2019\\\/210895Orig1s000TOC.cfm\"}]","notes":">"}]
[supplements] => [{"actionDate":"05\/12\/2020","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/022362s027,021776s047,210895s001lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/022362Orig1s027,021176Orig1s047,210895Orig1s001ltr.pdf\"}]","notes":">"}]
[actionDate] => 2020-05-12
)
)